Co-Authors
This is a "connection" page, showing publications co-authored by NADER EL-MALLAWANY and NMAZUO OZUAH.
Connection Strength
2.138
-
Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa. Blood Adv. 2020 08 25; 4(16):4007-4019.
Score: 0.776
-
Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. JCI Insight. 2023 Nov 22; 8(22).
Score: 0.243
-
Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania. HIV Med. 2023 06; 24(6):664-675.
Score: 0.229
-
Safety analysis of high-dose methotrexate in pediatric non-Hodgkin lymphomas. Pediatr Blood Cancer. 2022 11; 69(11):e29940.
Score: 0.224
-
Long-term outcomes for children and adolescents with Kaposi sarcoma. HIV Med. 2022 02; 23(2):197-203.
Score: 0.210
-
Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi. Clin Infect Dis. 2019 11 13; 69(11):2022-2025.
Score: 0.184
-
Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease. Infect Agent Cancer. 2018; 13:33.
Score: 0.171
-
Genetic errors of immunity distinguish pediatric nonmalignant lymphoproliferative disorders. J Allergy Clin Immunol. 2022 02; 149(2):758-766.
Score: 0.052
-
Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma. Cancers (Basel). 2020 Dec 02; 12(12).
Score: 0.049